HireMinds is seeking an experienced Sr. Director, Oncology Asset Lead to drive the vision, strategy, and execution of drug development programs with a well-positioned biotech local to Boston. This role is central to leading cross-functional teams through all stages of drug development, from preclinical to clinical milestones, with the ultimate goal of bringing innovative therapies to patients. You will lead the tumor targeting pipeline programs as a key decision maker and collaborate with R&D, CMC, and Clinical colleagues to orchestrate successful advancement of lead molecules.
You'll Be Responsible For:
Lead cross-functional teams to develop and execute comprehensive program strategies, incorporating preclinical, clinical, regulatory, and CMC manufacturing considerations into program plans.
Navigate internal and external drivers to adjust program strategies swiftly, minimizing risks and seizing opportunities.
Foster collaboration and alignment across departments to ensure the successful advancement of the lead program.
Maintain a keen understanding of competitive landscapes and strategic shifts impacting program goals and the overall oncology landscape.
Communicate program needs, progress, and recommendations clearly to executive management to enable data-driven decision-making.
Identify and evaluate academic, industry, and business partnerships to enhance program objectives.
Develop and execute publication strategies for program-related research and findings.
Build and lead high-performing teams, ensuring accountability and collaboration, while cultivating a culture of continuous learning.
Integrate competitive intelligence and differentiation insights into the overall program strategy.
Provide guidance on intellectual property strategy related to the program.
You'll Bring:
PhD, MD, or an advanced degree in biology, biomedical sciences, or a drug development-related field.
10+ years of industry experience in pharma, biotech, or research organizations with a track record of leading oncology drug development programs from IND to product launch.
Extensive experience in oncology drug development program go/no-go decision making with preference for IND to clinical phase success.
Expertise across multiple facets of drug development, including research, process development, manufacturing, clinical, and regulatory strategies.
Proven leadership and communication skills, with the ability to influence cross-functional teams and executive stakeholders.
Strong interpersonal skills and experience fostering a collaborative, empowered, and learning-focused environment.
This is a hybrid role (3-days in office) based in Watertown, Massachusetts, offering a dynamic and impactful opportunity to shape the future of oncology therapies.